Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What kind of a co. puts out 'nothing' news on a Saturday night? I've NEVER seen this before.
Also - did anyone who got the post card in the mail 4 or 5 months ago from California ever get to speak to anyone on their toll-free phone numbers? I left my name andnumber 3 times over 2 months and NEVER got a return call..... At this point I'd be happy to get out even ($1.10 per share)....
Why didn't I buy AMW I at .17 2 weeks ago? WHY? WHY? WHYYYYY??? LOL
Good luck to us all....
What's happening here - besides nothing? We were at .90 on no news or financials only 6 weeks ago - Oct. 18th....... Looks like Goldman coverage was over rated.
What happened? Where did the buyers go?
Thanks. Good Luck to us all today and every day!
What are you basing those numbers on? What has changed since I got in last August that would get us back up to over $1.00 or more? I haven't seen any spectacular news.... Thanks in Advance.
Good Luck to us all. GO SRPX GO GO GO!!
Blue Horseshoe: How high do you think we'll go? I've been here since August at $1.10 per share...... Good Luck to us all....
Thanks Det... eom
Steady higher highs and higher lows!! Sounds good to me!
Is this a new stock? I can't find any history on it. I'm guessing it's a pinky? TIA.
Hey - POT G was 'playable' for a month or so...
Possibly the same here.. YES its a POS P & D, but I've learned over the years to make it and take it where you can...
Good Luck to us all!
GO GO GO GO GO GO MILV GO GO GO GO GO GO !!!!!!!!!!!!
Det: What's the link for the video? TIA! Think we'll EVER see .35-.50 here??
And MORE NEWS this morning! Ahhh CHU!!! :
We should finally fly over .15 today:
Nature's Bioceuticals Finalizes The Purchase of Cold and Flu Formula
CAPE CORAL, Fla., Nov. 10, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures, Inc. (MILV.pk - News) announced that it has executed the closing documents for the purchase of the cold and flu formula and now has the exclusive rights to the formula.
The common cold, an infection of the upper respiratory tract, is caused by any of 200 different viruses. The viral infection and the immune system's battle against it produce the all-too-familiar symptoms: sore throat, nasal congestion, runny nose, watery eyes, hacking cough and sometimes fever. It is a viral infection, so things like antibiotics, which are often mistakenly prescribed for colds, won't help. Giving antibiotics for viral diseases is a distressingly common practice. Studies have shown that 60 percent of patients who went to the doctor with one of the viruses that cause the common cold received an inappropriate prescription for antibiotics.
Sales of cold and flu formulas slipped slightly between 2009 and 2010, down 1.2% for sales of $3.8 billion. Helping to decelerate the losses was both competitive threats from alternative remedies and increased sales of private label products across all segments of the market, as consumers sought out more affordable remedies during the poor economy, often with the view that these medicines work just as well as national brands. However, most of these products simply mask the symptoms and do little or nothing to address attacking the cause. Many people have lost confidence in OTC products due to bad press, a number of recalls and FDA recommendations. Further, on March 2, 2011 the FDA announced steps to remove more than 500 prescription cold, cough, and allergy products from the market because of potential safety concerns. The FDA asked companies to stop manufacturing the 500 products within 90 days and stop shipping them within 180 days. Some manufacturers were required to stop making and shipping their products immediately.
Robert deZanger, CEO of Natures Bioceuticals stated, "We are pleased to add this spectacular natural medicine to our existing product line. Although the Cold and Flu market is flooded with a number of established brands, we are confident that we can capture a significant portion of the market with an all natural product that really works. The goal we have set is to capture 3% of the US market within a 3 year period, which could possibly generate over $100,000,000 in revenues for the company. Our formula contains over twenty different herbs that are all 'active ingredients'. The formula provides relief from the cold and flu symptoms, but more importantly, it boosts the body's immune response to combat the cause of the virus. When taken at the onset of symptoms the formula has shown the ability to reduce the severity and duration of a cold or flu. It has also in many cases arrested the virus before symptoms are able to come to fruition. The inventor has for many years been conducting research to find a 'cure' for the common cold. This formula was invented as a result of that ongoing research. We now intend to hire an independent testing group to do a clinical trial(s) to formally document the results we have achieved and publish a report for the medical community."
About Nature's Bioceuticals:
Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs.
Nature's line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA".
In addition to historical information, this release contains forward-looking statements. Mistral Ventures, Inc. and/or Nature's Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature's Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as "expects," "intends," "believes," "anticipates," "should," "likely," and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Neither Mistral Ventures, Inc. nor Nature's Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company's financial statements by the Company and its Audit Committee; modification of the Company's accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.
Media Contact:
Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com
www.naturesbioceuticals.com
SOURCE Nature's Bioceuticals
Source: PR Newswire (November 10, 2011 - 7:00 AM EST)
News by QuoteMedia
www.quotemedia.com
NEWS last night after market closed:
Nature's Bioceuticals Appoints Dr. Donald Newman to the Board of Directors
CAPE CORAL, Fla., Nov. 9, 2011 /PRNewswire/ --Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk), is please to announce the appointment of Dr. Donald Newman to the Board of Directors.
Dr. Newman owns and operates a successful holistic dental practice, Tower Dental, in Boca Raton, Florida. He is an active member of The South Palm Beach Dental Society, American Dental Holistic Society, and The Gerson Institute, a non-profit organization located in San Diego, California, dedicated to the alternative, non-toxic treatment of cancer and other diseases. The Gerson Therapy is a safe, natural treatment developed by Dr. Max Gerson in the 1920s that uses a variety of organic foods, detoxification and natural supplements to activate the body's ability to heal itself. Over the past 60 years, thousands of people have used the Gerson Therapy to recover from so-called "incurable" diseases such as cancer, diabetes, heart disease and arthritis.
Dr. Newman has a strong working knowledge of herbs and various alternative treatments. Dr. Newman is currently conducting research on the relationship between energized minerals in vegetables and their health benefits. He is also an advocate of global water quality issues as it relates to overall health and is studying alternative purification methods and ionic enhancement of waters.
Dr. Newman attended and graduated from Adelphi University 1969--1973 BA, Baltimore School of Dental Medicine 1974--1978 DDS and was a Captain in the United States Air Force 1978--1981.
Robert deZanger, CEO of Natures Bioceuticals, stated, "We welcome Dr. Newman as an addition to our Board. His working knowledge of natural supplements as they relate to the treatment of health problems is a perfect fit for our company. Also, we feel that the outcome of some of his research may bring additional value to the company in the future."
About Nature's Bioceuticals:
Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared toward treating specific medical conditions. These medicines are all-natural and derived from botanicals and mineral bases. Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs.
Nature's line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA."
In addition to historical information, this release contains forward-looking statements. Mistral Ventures Inc. and/or Nature's Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature's Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as "expects," "intends," "believes," "anticipates," "should," "likely," and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Neither Mistral Ventures, Inc. nor Nature's Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company's financial statements by the Company and its Audit Committee; modification of the Company's accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.
Media Contact:
Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com
www.naturesbioceuticals.com
SOURCE Nature's Bioceuticals
Source: PR Newswire (November 9, 2011 - 5:46 PM EST)
News by QuoteMedia
www.quotemedia.com
$3.95 Stock Trades at OptionsHouse. Why Pay More?
Market Summary
Symbol Last Tick Chg
DJIA RT 11780.94 -389.24
Nasdaq RT 2621.65 -105.84
S&P 500 1229.10 -46.82
CBOE Volatility 36.16 8.68
Russell 2000 718.86 -36.41
30 Yr Bond 30.16 -0.16
10 Yr Bond 19.55 -0.25
5 Yr Bond 8.62 -0.01
© quotemedia.com
Google
Custom Search
Wrong again Space Cadet! LOL Looks like we're going to run to HOD at close and then another PR before open then To Da MOON!!!
(Hey - I bet YOU can see the moon up close Spaceman!! HEE HEE
Looks like maybe the day traders are getting out early? Down over a penny in 5 minutes. Hope it's just the MMs trying to get shares for the next leg up! Should we have another PR today!?!?! LOL
He's probably also "spacebound"! Why would a total stranger care about us? The sky is falling, the sky is falling!!
Troubling that we didn't break .14 today though. It REALLY wanted to!
Volume and price spiked yesterday and Monday when they hit mid-day!
Good Luck!
JUST got this email 1 minute ago - maybe it will push us over .15! Hey - we're already at .13!! Not as far to go as yesterday!
Good Luck to us all!
EMAIL: (from Penny Stock Exprt)
Today's pick is: MILV
Hi Everyone,
For our new subscribers, Welcome!
MILV is gaining incredible momentum by the minute. It was up 20% in early trading, and could be quickly headed past 15 cents any moment now.
It seems like everyone is wathing MILV closely now. Are you as well?
The volume accumulation is very strong and patterns are indicating the possibility of a massive run from here on.
Our last pick had a very similar chart right before it ran into the $1.20 range.
MILV is continuing its climb towards the $1 price target that it was recently given in the seeking alpha article.
At current levels we may still be looking at 900% gains if it reaches those levels which is nothing to laugh about!
MILV announced some big news this morning about the Sinusitis Formula. They will commence sales! Read more about this important news on yahoo finance.
One way or another we think that MILV is a company that deserves our attention.
Remember to tell your friends and family, and discuss MILV on Twitter, Facebook, Google+ and all other social networks and spread the word. If you don't tell them they might get angry at you for having possibly caused them to miss such an opportunity.
You can also visit the company's website at NaturesBioceuticals dot com
Got MILV?
Happy Trading!
Your PennyStocksExpert Editor.
Nice to see that we held near .13 during the 1st hour shake! What are your thoughts on the rest of today and tomorrow?? TIA.
GO GO GO GO GO MILV GO GO GO GO GO !!!!!!!!!!
I almost sold at .14 yesterday - but the way it was flying I thought we'd close into HOD. I got shaken out at .05 two weeks ago after buying in at .06; but got back in last week at .075 when I saw signs of another POT G !! After the big drop yesterday, I thought it was over but recovered nicely into close at .121. Even as I write this - I don't know what to make of it. L2 is useless to me as it changes in a split second.... I'm not a charter or techie.
Do you think we'll hit .15+ today or do you think we have a big drop coming? How do you trade? Tech?
I think that's a GREAT idea - your interactive sight! What can we do to assist you?
I wonder is this is just another shake or, or - or.... damn it's tough to watch this!
Do you think there will be a lot of profit taking by day traders from 3 - 4pm today?
I may sell half at .15, instead of selling it all. At that point I have a double and would have those shares for free. BUT - the greed in me is thinking POT G... POT G... I could make up for all my losses on this one.... But we know that's probably not the case.
UBSS is now at .15 on the ask... and 7 bidding .13 or more now.
Were you in POT G? I can't believe a completely worthless company ran for what seemed like forever! Hmmmm - Wait - isn't that... Oh yeah! Deja Vu!!! LOL and Best of Luck!
I know though - when this does drop - and it WILL - it will probably drop like a rock....
Hey - Nuttin's more fun than a big lunchtime run - except an even bigger run into close!!
No - I still have my GTC Sell at .15 - although now I'm thinking of only selling half - Ewwwww - who knows.....
I'm thinking the pump emails where they said 'getting near .15' is what's pushing us??? It started going up yesterday too at 1:30 when they put out their emails.... They're creating "Fear of Loss" among those who aren't in..... I just hope the new buyers - and us - don't see a loss!!
Still going up - .1245 now!
APS and PSE just sent more emails:
Today's pick is: MILV
Hi Everyone,
For our new subscribers, Welcome!
MILV is going crazy this morning. It has shattered past 10 cents and is nearing 15 cents very quickly. At this rate it will be impossible to buy it low comes tomorrow.
We think that from this point on MILV is bound for greatness. It has already almost quadrupled since our initial alert and its chart pattern is nearly replicating the last pick's. The last pick went from 5 cents to over $1.20 on a very similar uptrend pattern.
Even at current numbers we may still be looking at 800% gains if it reaches those levels which is nothing to laugh about!
MILV is continuing its climb towards the 1$ price target that it was recently given in the seeking alpha article.
Is Christmas here early for our members?
Remember to tell your friends and family, and discuss MILV on Twitter, Facebook, Google+ and all other social networks and spread the word. You can also visit the company's website at NaturesBioceuticals dot com
Watch MILV closely! The company announced this morning that it is commencing production for its Breathing Relief formula!
Happy Trading!
Your AwesomePennyStocks Editor.
rarefind - you don't think we have enough gas left to get to .15 - .20 in the next few days??
MAYBE .20 - .30, or even higher like POT G did if they keep printing daily PR's...but who knows, jmho.. Looking at L2 right now it seems we should be over - and stay over .12 in the next little bit - BUT that can change in a second and drop like a rock.... Been THERE a few times too!
Bids - Asks have crossed a LOT in the past 1/2 hour. I hope that's only because of the high volume. A few minutes ago .114 and .12 printed but I never saw it get there on L2. And I sure hope the gap (.094 - .0945) doesn't fill for a long while!!
THAT was FAST! In less than 2 minutes we went from .106 to .113 - Guess this is OUR time!!
Nuttin's more fun than an early morning run!! I wish we'd just start jumping up in full pennies or 1/2 pennies!! This 1/1oth is driving me crazy!!!
.105 up - .11's next!! YIPPEEEEEEE !!!!
Good Morning rarefind and all. L2 pre-market is .0965 x .097. Let's hope we just finally break loose! (I almost feel like trying to sell into open and buy back in at pullback - but if I did that - it would never look back! LOL I'm staying put to .15
GO GO GO GO GO GO MILV GO GO GO GO GO GO !!!!!!!!!!!!
Thanks - I may have seen that one in the past. Also - if you play the subs - research 'reverse split repeat offenders'. It tells you not only the companies that dilute, reverse; and then do it again - but it also gives the CEO/Owners info as some of them own more than 1 penny company... Don't remember the site - just google the info.
More NEWS out at 7am this morning. The PR machine is on - just hope we run like POT G did!!
November 8, 2011 - 7:00 AM EST
Nature's Bioceuticals Commencing Production of Its Breathing Relief Formula
CAPE CORAL, Fla., Nov. 8, 2011 /PRNewswire/ -- Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk) announced that it is finalizing arrangements to commence production of its Breathing Relief Formula. This is the formula that the company has previously referred to as its COPD formula, which will now be marketed as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA), thus requiring a name change.
Robert deZanger, CEO of Nature's Bioceuticals stated, "I am extremely satisfied that our new strategy allows us to market this product as a supplement immediately, instead of waiting many years and spending hundreds of millions of dollars seeking FDA approval as a drug. We have begun placing orders for the natural ingredients, bottles, etc. and expect to have product inventory ready for sale within 30 to 60 days. We are also finalizing our new product labeling and packaging, which we feel provides the proper image for our company and products. We anticipate sales in excess of $10,000,000.00 the first year and then expanding and exponentially thereafter."
About Nature's Bioceuticals:
Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs.
Nature's line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA"
In addition to historical information, this release contains forward-looking statements. Mistral Ventures, Inc. and/or Nature's Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature's Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as "expects," "intends," "believes," "anticipates," "should," "likely," and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Neither Mistral Ventures, Inc. nor Nature's Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company's financial statements by the Company and its Audit Committee; modification of the Company's accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.
Media Contact:
Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com
www.naturesbioceuticals.com
SOURCE Nature's Bioceuticals
Source: PR Newswire (November 8, 2011 - 7:00 AM EST)
Then let's just "Set it and Forget it" at .02 - which is where I have my GTC Sell IF I get taken out of 1/2 my shares at .008, and let's hope it happens by Christmas!?!?!? Hey - with this thing it COULD happen in an hour! Good Luck to us all!! Then again - if it was .10 - .11 3 months ago - why can't it go back in another 3 months??? (Guess I'm getting greedy - but hey - I have a LOT tied up here and really didn't buy in to get out even or with a 'small' profit)....
If one of us picks up on that site - let's post it for everybody's benefit!!!
Hi Alries! I see your still "stuck" here too! I bought another 750,000 shares a week ago at .0015 to abg. down to .0056 and didn't even THINK about selling at .0025. DUMB DUMB DUMB. Have 1/2 mil. at .008 andother 1/2 at .02 - So I may be here the rest of my life - then again - it could happen in a DAY!! Oh well - Good Luck to us all! Oh how I wish I sold my first buy for a 12% gain at .11 !! LOL
Sometimes OTC Stocks is reliable, jmho - but I've seen them ALL have absolute BOMBS..... They can only control so much. The PUMP that boggles my mind the most is POTG/ Go read up on it from BEFORE the beginning of the climb and read all through it - right up until now. I can't believe it did what it did.... I'm no expert though - so read up on it all yourself... and GOOD LUICK to us all!
GO GO GO GO GO MILV GO GO GO GO GO !!!!!!!!!!!